Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-activated Receptor (PPAR) Activation: a New Potential Multi-target Therapeutic Strategy for the Treatment of Alzheimer's Disease

Overview

Journal Neural Regen Res

Date 2019 Sep 20

PMID 31535650

Citations 9

Authors

Leonardo Brunetti

Antonio Laghezza

Fulvio Loiodice

Paolo Tortorella

Luca Piemontese

Affiliations

Soon will be listed here.

Citing Articles

Role of copper chelating agents: between old applications and new perspectives in neuroscience.

Leuci R, Brunetti L, Tufarelli V, Cerini M, Paparella M, Puvaca N Neural Regen Res. 2024; 20(3):751-762.

PMID: 38886940 PMC: 11433910. DOI: 10.4103/NRR.NRR-D-24-00140.

Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer's drugs.

Piemontese L Neural Regen Res. 2023; 18(12):2671-2672.

PMID: 37449616 PMC: 10358667. DOI: 10.4103/1673-5374.373685.

Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer's Disease.

Carocci A, Barbarossa A, Leuci R, Carrieri A, Brunetti L, Laghezza A Antioxidants (Basel). 2022; 11(9).

PMID: 36139705 PMC: 9495854. DOI: 10.3390/antiox11091631.

Can foods influence the onset and progress of neurodegenerative diseases?.

Piemontese L, Brunetti L, Leuci R Neural Regen Res. 2022; 17(11):2443-2444.

PMID: 35535892 PMC: 9120676. DOI: 10.4103/1673-5374.335810.

A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).

Leuci R, Brunetti L, Laghezza A, Piemontese L, Carrieri A, Pisani L Molecules. 2022; 27(3).

PMID: 35164223 PMC: 8839882. DOI: 10.3390/molecules27030958.

References

Basavarajappa B, Shivakumar M, Joshi V, Subbanna S . Endocannabinoid system in neurodegenerative disorders. J Neurochem. 2017; 142(5):624-648. PMC: 5669051. DOI: 10.1111/jnc.14098. View

Piemontese L, Vitucci G, Catto M, Laghezza A, Perna F, Rullo M . Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease. Molecules. 2018; 23(9). PMC: 6225478. DOI: 10.3390/molecules23092182. View

Piemontese L, Fracchiolla G, Carrieri A, Parente M, Laghezza A, Carbonara G . Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175. Eur J Med Chem. 2014; 90:583-94. DOI: 10.1016/j.ejmech.2014.11.044. View

Meinig J, Ferrara S, Banerji T, Banerji T, Sanford-Crane H, Bourdette D . Targeting Fatty-Acid Amide Hydrolase with Prodrugs for CNS-Selective Therapy. ACS Chem Neurosci. 2017; 8(11):2468-2476. PMC: 6342467. DOI: 10.1021/acschemneuro.7b00239. View

Hiremathad A, Piemontese L . Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy. Neural Regen Res. 2017; 12(8):1256-1261. PMC: 5607816. DOI: 10.4103/1673-5374.213541. View

Bedse G, Romano A, Lavecchia A, Cassano T, Gaetani S . The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease. J Alzheimers Dis. 2014; 43(4):1115-36. DOI: 10.3233/JAD-141635. View

Piemontese L, Cerchia C, Laghezza A, Ziccardi P, Sblano S, Tortorella P . New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity. Eur J Med Chem. 2017; 127:379-397. DOI: 10.1016/j.ejmech.2016.12.047. View

Agarwal S, Yadav A, Chaturvedi R . Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders. Biochem Biophys Res Commun. 2016; 483(4):1166-1177. DOI: 10.1016/j.bbrc.2016.08.043. View

Fernandez-Ruiz J, Romero J, Ramos J . Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others. Handb Exp Pharmacol. 2015; 231:233-59. DOI: 10.1007/978-3-319-20825-1_8. View

10.

Piemontese L . New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge. Neural Regen Res. 2017; 12(3):405-406. PMC: 5399716. DOI: 10.4103/1673-5374.202942. View

11.

Piemontese L . An innovative approach for the treatment of Alzheimer's disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions. Neural Regen Res. 2018; 14(1):43-45. PMC: 6262998. DOI: 10.4103/1673-5374.241043. View

12.

Panlilio L, Justinova Z, Goldberg S . Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacol Ther. 2013; 138(1):84-102. PMC: 3662489. DOI: 10.1016/j.pharmthera.2013.01.003. View